Carol Karp
Algemeen Adviseur bij PROTHENA CORPORATION PLC
Vermogen: - $ op 30-04-2024
Profiel
Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions such as Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
Ms. Karp obtained her undergraduate degree from Rochester Christian University and New York University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Carol Karp
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTHENA CORPORATION PLC | Algemeen Adviseur | 15-12-2016 |
| Rochester Christian University | Directeur/Bestuurslid | - |
Eerdere bekende functies van Carol Karp
| Bedrijven | Functie | Einde |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Compliance Officer | 01-01-2014 |
| Janssen Alzheimer Immunotherapy | Algemeen Adviseur | 01-01-2013 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Algemeen Adviseur | 02-05-2011 |
| VIVUS, INC. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Carol Karp
| Rochester Christian University | Undergraduate Degree |
| New York University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Powderject Technologies BV | |
| Janssen Alzheimer Immunotherapy |
